In late 2021 a new consensus report, The Management of Type 1 Diabetes in Adults, was published jointly by American Diabetes Association (in Diabetes Care) and European Study for Diabetes (EASD) (in Diabetologia). The report was developed by 14 content experts. The focus, interestingly, is on people 18 years of age and older.
Until recently the only ways to take insulin, other than using an insulin pump, was via traditional pens or vial and syringe. Due to engineering and technological innovation there’s a growing cadre of insulin delivery devices called connected insulin delivery devices. In this blog for T1D Exchange, I define “connected” devices and review the rationale for their need.
While there’s LOTS of talk about what are now referred to as Automated Insulin Delivery (AID) systems (rather than artificial pancreas systems), many people don’t fully understand how these devices will work and what they’ll actually accomplish. This blog written for the T1D Exchange, describes the evolution to AID systems, details the current and near-future devices in a related table and discusses the clinical and mental health benefits of AID systems.